secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001664710-24-000026
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Keros CMO Simon Cooper resigns effective March 12, 2024
-------------------------------------------------------

- Simon Cooper, M.B.B.S., voluntarily resigned as CMO effective March 12, 2024, to pursue other opportunities.
- Resignation is not due to any disagreement with the company.
- Company has commenced a search for a new Chief Medical Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000026/0001664710-24-000026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471024000026/kros-20240229.htm
  HTML page:      https://secwatch.observer/filing/0001664710-24-000026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer